SCHEMBL14664352

SCHEMBL14664352

CC(=O)NC1CC(C(C)=O)CC(OC2OC(CO)C(O)C(O[C@@H](CC3CCCCC3)C(=O)O)C2OC(=O)c2ccccc2)C1OC1OC(C)C(O)C(O)C1O

nearest known ligand 0.68

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SELE P16581 16/20 0.68
▸ SELP P16109 5/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15214014 0.89 SELE (0.65) SELESELP
SCHEMBL14667866 0.89 SELE (0.55) SELESELP
SCHEMBL11982132 0.87 SELE (0.70) SELESELP
SCHEMBL12309895 0.86 SELE (0.71) SELESELP
SCHEMBL16378227 0.86 SELE (0.67) SELESELP
SCHEMBL16369311 0.86 SELE (0.67) SELESELP
SCHEMBL22050894 0.85 SELE (0.77) SELESELP
SCHEMBL18938430 0.85 SELE (0.77) SELESELP
SCHEMBL13657266 0.85 SELE (0.65) SELESELP
SCHEMBL11981958 0.85 SELE (0.79) SELESELP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8361975-B2 Compounds and methods for treatment of sickle cell or complications associated therewith GLYCOMIMETICS, INC. (US) 2013-01-29 — — US disclosed
Send feedback